OTAVA Ltd. offers a new set of target-focused libraries with Enhanced Intellectual Property Potential. This set of libraries with a variety of novel compounds is an excellent starting point for research chemists and biologists in drug discovery.

OTAVA offers its own specially designed Fragment Library. The central purpose of the library is to provide fragments that will bind to the binding site(s) of any target and will also provide suitable starting points for drug discover.

OTAVA offers 49 protein kinase ligand-based focused libraries prepared on on the base of 500,000 drug-like compounds.

OTAVA offers a number of INHIBITORS and other biologically active compounds modulating activity of distinct macromolecular targets

More than 200 new focused compound libraries for screening!

This section contains information on current Otava's products and services (downloadable files in PDF format).

Products & services booklet (09. 2007)

---

Protein Kinase CK2: new perspectives

---